comparemela.com

Latest Breaking News On - Babu rangisetty - Page 1 : comparemela.com

Vizag s Biophore to manufacture indigenous anti-Covid pills for global market

The manufacturing is in collaboration with Rakshit Group, which is expected to reduce the dependence on imports, mainly from China

Jagadeesh babu rangisettyRakshit groupBiophore india pharmaceuticalsDrugs controller generalDeccan chronicleBabu rangisettyRakshit groupDrugs controller general of indiaJagadeesh babu rangisettyCovid pills

Biophore applies to DCGI for emergency-use approval for COVID treatment drug

NEW DELHI, Jun 11: Biophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) for obtaining

Andhra pradeshJagadeesh babu rangisettyBiophore india pharmaceuticals onBiophore india pharmaceuticalsDrugs controller generalActive pharmaceutical ingredientVasoactive intestinal peptideBabu rangisettySulfobutyl etherஆந்திரா பிரதேஷ்மருந்துகள் கட்டுப்படுத்தி ஜநரல்செயலில் மருந்து மூலப்பொருள்

Biophore applies to DCGI for emergency-use approval for Covid treatment drug Aviptadil

Biophore India Pharmaceuticals has approached the Drugs Controller General of India for an emergency-use approval for Aviptadil, which is used in the treatment of moderate to severe cases of Covid.

Andhra pradeshJagadeesh babu rangisettyBiophore india pharmaceuticals onBiophore india pharmaceuticalsDrugs controller generalActive pharmaceutical ingredientVasoactive intestinal peptideBabu rangisettySulfobutyl etherIophore aviptadilViptadil euaஆந்திரா பிரதேஷ்மருந்துகள் கட்டுப்படுத்தி ஜநரல்செயலில் மருந்து மூலப்பொருள்

Biophore seeks DGCI nod for emergency use of Covid drug

Hyderabad-based firm says it has developed the product which is backward integrated with its in-house API

Jagadeesh babu rangisettyVasoactive intestinal peptideBabu rangisettySulfobutyl ether

Biophore applies to DCGI for emergency-use approval for COVID treatment drug

Biophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) for obtaining emergency-use approval for Aviptadil, used in the treatment of moderate to severe cases of COVID-19.

Andhra pradeshJagadeesh babu rangisettyBiophore india pharmaceuticals onImage sourceBiophore india pharmaceuticalsDrugs controller generalIndia pharmaceuticalsActive pharmaceutical ingredientVasoactive intestinal peptideBabu rangisettySulfobutyl etherCovid treatment drugOvid treatment medicineCgi approval for covid treatment medicineOvid cases indiaEmergency use drug

vimarsana © 2020. All Rights Reserved.